Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2020

Jul 1, 2020

3091_iss_2020-07-01_10cba780-e28c-4ff4-aa7a-10452ce94507.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Fjärde AP-fonden

Instrument

Instrument Aktier
Before the transaction
Shares 3,055,755
Voting rights 3,055,755
Transaction
Reason for major shareholding notification Buy
Date 30/06/2020
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 3,140,755
Directly held voting rights 3,140,755
Indirectly held voting rights 0
Percentage
Directly held shares 5.11 %
Directly held voting rights 5.11 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.11 % 3,140,755
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.11 % 3,140,755
Group
total
holdings
Voting rights
3,140,755
Percentage of voting rights 5.11
Published
01/07/2020 21:21
Contact
Name
Jannis Kitsakis
Phone
070-6038023 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25